我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI，丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。它可以让您创建简单易行的服药时间表，并设置隐藏和个性化的提醒。

全部新闻 / 五月 2020

归档

✕

28 五月 2020

4661

BHIVA & EACS release updated statement on COVID-19 & HIV

BHIVA & EACS release updated statement on COVID-19 & HIV

On Monday, May 25, the British HIV Association (BHIVA), in collaboration with the European AIDS Clinical Society (EACS), DAIG, GESIDA and the Polish AIDS Science Society, released an updated statement on the risks of COVID-19 coronavirus infection for people living with ...

18 五月 2020

4248

Every two-month injections show higher efficacy than oral PrEP

Every two-month injections show higher efficacy than oral PrEP

Today, Monday 18th May 2020, the HIV Prevention Trials Network (HPTN) announced the interim analysis of their study HPTN 083 which was evaluating the efficacy and safety of long-acting injectable cabotegravir for the prevention of HIV. In the study cabotegravir was found ...

15 五月 2020

4567

Gilead agrees licenses for generic manufacturing of Remdesivir

Gilead agrees licenses for generic manufacturing of Remdesivir

Gilead Science, the American biotech company behind the antiviral agent Remdesivir has entered into a non-exclusive licensing agreement with five generic manufacturers from India and Pakistan to produce and market the drug, which has the potential for antiviral activity ...

15 五月 2020

5007

Multi-month HIV prescribing prohibited in many countries

Multi-month HIV prescribing prohibited in many countries

Current advice from international experts such as the WHO, UNAIDS, the Global Fund, PEPFAR, EACS and others is that during the Coronavirus pandemic people living with HIV should be given prescriptions of HIV antiretrovirals (ART) covering three to six months. However, ...

15 五月 2020

4893

Life4Me+ and EACS launch a joint initiative for IDAHOBIT

Life4Me+ and EACS launch a joint initiative for IDAHOBIT

To mark International Day Against Homophobia, Transphobia and Biphobia (IDAHOBIT) on Sunday 17th May 2020 the European AIDS Clinical Society (EACS) and Life4Me+ interviewed a number of HIV clinicians and activists with the aim of breaking down stigma and discrimination towards ...

6 五月 2020

3950

EACS & BHIVA release updated guidance for HIV & COVID-19

EACS & BHIVA release updated guidance for HIV & COVID-19

The European AIDS Clinical Society (EACS) and the British HIV Association (BHIVA) have released an updated statement on the risks of COVID-19 for people living with HIV (PLHIV). Data on ongoing worldwide studies of new coronavirus therapy and infection risks for PLHIV ...

6 五月 2020

4437

New monoclonal antibody treatment could be effective against COVID-19

New monoclonal antibody treatment could be effective against COVID-19

CytoDyn, an American pharmaceutical company, has announced that it has made some progress in research into a therapy against COVID-19, a disease caused by the new SARS-CoV-2 coronavirus. It would appear that Leronlimab is able to help mitigate the ‘cytokine cascade’, ...

6 五月 2020

4696

New data on Remdesivir and COVID-19

New data on Remdesivir and COVID-19

On Wednesday April 29th 2020, an article was published in the medical journal Lancet that presented updated data on the antiviral activity of the drug Remdesivir against the new SARS-Cov-2 coronavirus. Analysis data showed that treatment with remdesivir was not associated ...